Introduction {#S1}
============

The pulsed electric field (PEF) technology is a mild, non-thermal method that processes various biological materials with intermittent high-intensity electric energy ([@B5]). Compared to other thermal processing techniques, PEF generates substantially less heat, which ensures better preservation of flavor, color and nutrition in food products. PEF also offers obvious advantages over both enzyme- and chemical-based cold processing methods in that it does not introduce any potentially quality-degrading additives. One of the main applications of PEF in food and beverage industry is the inactivation of microbial pathogens. For example, liquid whole egg processed by combination of PEF and mild thermal treatment at 55°C exhibited significantly longer shelf-life at 4°C than those treated with heat alone ([@B21]). In another study, *Listeria* monocytogenes populations in different liquid milk products were reduced by a factor of 10^4^ with a 0.6-ms PEF treatment at 50°C ([@B54]). Recently, PEF has also been evaluated for the preservation of solid food products, such as fruits ([@B60]; [@B76]), and for facilitating the extraction of valuable chemicals from plants and fungi ([@B14]; [@B75]).

Currently, studies that aim to investigate the mechanism of PEF-induced cell inactivation have focused predominantly on its deleterious effects on membrane integrity ([@B71]; [@B74]). It is generally accepted that cell membranes exposed to PEF are locally distorted by electromechanical compression, culminating in pore formation and even membrane rupture ([@B72]). In comparison, there have been very few studies on whether PEF also affects other cellular components or processes, particularly proteins ([@B27]; [@B55]). In this regard, it has been demonstrated that PEF could induce significant structural changes in solid-state egg white proteins ([@B52]). Meanwhile, PEF-processed malting barley seeds showed reduced α-amylase expression compared to the untreated controls ([@B10]). In recent years, the rapid development of proteomic technologies has allowed researchers to systematically analyze proteome-wide changes in response to external stimuli. For example, [@B55] examined the proteomic changes in PEF-damaged *Escherichia coli* DH5α cells with or without a 1-h recovery in Luria-Bertani (LB) medium after the treatment. The recovery and non-recovery groups showed different sets of differentially expressed proteins, which were mainly associated with cell metabolism, membrane structure, aerobic respiration, and protein folding ([@B55]). There have also been a number of other studies regarding the effects of PEF treatment or electroporation on the mRNA and/or protein expression in various prokaryotic and eukaryotic cells ([@B43]; [@B19]; [@B79]). However, further research is needed in order to provide a more comprehensive and detailed elucidation of how PEF disrupts various aspects of cellular structures and functions to achieve its sterilizing effects.

Materials and Methods {#S2}
=====================

Cell Culture and PEF Treatment {#S2.SS1}
------------------------------

The *E. coli* strain CGMCC44102 was obtained from the China General Microbiological Culture Collection Center (CGMCCC), and cultured in LB medium at 150 rpm and 37°C to a final optical density (OD) of 1.0 at 600 nm. Subsequently, 1 mL of the culture broth was collected and centrifuged at 8000 rpm, 4°C for 2 min. The cell pellet was re-suspended in 2 mL of ice-cold 0.1% (w/v) bacteriological peptone solution (Solarbio Life Science, China) and divided into 70 μL aliquots. For PEF treatment, each aliquot was pipetted into a new, sterile 1.0-mm electroporation cuvette and pulsed using a BTX ECM830 Square Wave Electroporation System (BTX, United States) based on a protocol described previously ([@B32]). The cell density in the aliquot was approximately 10^8^ CFU/mL and electric conductivity was 0.19 mS/cm. The general setup of the device and the wave shape of the pulse were illustrated in [Figure 1](#F1){ref-type="fig"}. After treatment, the cells were serially diluted and counted based on a previously described protocol ([@B1]) to calculate the inhibition rate. To achieve different cell killing levels, we employed different sets of pulse conditions as previously described. For a cell killing extent of 95 ± 2.0%, pulse intensity, number and duration were set to 14.5 kV⋅cm^--1^, 26 and 67 μs, respectively. The killing extent was 51 ± 1.3% with the treatment parameters of 6.10 kV⋅cm^--1^, pulse number of 54, pulse duration of 77 μs. And when the pulse intensity was 2.88 kV⋅cm^--1^, pulse number was 62, pulse duration was 82 μs, the killing extent was 29 ± 0.7%. Based on measurement on an RC05 Infrared Thermal Imaging Camera (Rinch Industrial, China), the culture temperature showed an average increase of less than 3°C following the PEF treatment, which would not significantly reduce the viability of the cells.

![**(A)** Schematic diagram of the PEF device setup ([@B32]) and **(B)** wave shape of the pulse.](fmicb-10-02644-g001){#F1}

The electroporated aliquots were pooled together to a final volume of 3 mL (∼43 aliquots) and divided in a clean 1.5 mL microcentrifuge tube placed on ice. This was used as an experimental replicate. The pooled *E. coli* suspension was then centrifuged at 4°C, 5,000 × *g* for 5 min, washed twice with and then re-suspended in ice-cold phosphate-buffered saline (PBS), and then quickly flash-frozen in liquid nitrogen for storage at −80°C. For controls, a mock treatment without the application of PEF was performed, with identical downstream procedures. The whole experiment described above was conducted in triplicate.

Protein Extraction {#S2.SS2}
------------------

The cell pellet of strain was suspended in 200 μL SDT lysis buffer consisting of 4% (w/v) sodium dodecyl sulfate (SDS), 0.15 M Tris--HCl at pH 7.6 and 100 mM dithiothreitol (DTT), and transferred to a 2-mL tube pre-filled with 1/3 vol of quartz sand and ten steel grinding beads. The resultant mixture was subsequently homogenized twice on a Fastprep-24 homogenizer (MP Biochemicals, United States) at 6.0 m/s, followed by ten cycles of 10-s sonication at 80 W with 15-s intervals. The homogenate was boiled for 15 min and centrifuged at 14,000 × *g* for 40 min, after which the supernatant was sterilized with a 0.22-μm filter. Total protein in the filtrate was quantified with a BCA Protein Assay Kit (Bio-Rad, United States). All filtered protein extracts were stored at −80°C until use.

Trypsin Digestion {#S2.SS3}
-----------------

Based on the BCA assay results, 200 μg of the extracted protein were denatured with 30 μL of SDT buffer and incubated at 56°C for 30 min. Low-molecular-weight components, including SDS and DTT, were removed by repeated ultrafiltration through a Microcon 10-kDa Centrifugal Filter Unit (Millipore, United States) with UA buffer, which consisted of 8 M urea in 150 mM Tris--HCl at pH 8.0, as the wash buffer. The sample was mixed with 100 μL of 100 mM iodoacetamide in UA, followed by a 30-min incubation in darkness. The filter unit was subsequently washed with 100 μL of UA twice and 100 μL of 25 mM NH~4~HCO~3~ twice. The resultant protein sample was digested by adding 4 μg of trypsin (Promega, United States) in 40 μL of 25 mM NH~4~HCO~3~ to the filter unit and then incubating at 37°C for 18 h. The filter unit was centrifuged at 13,400 rpm for 30 min and the peptide products were collected as a flow-through. The filter unit was next washed with 40 μL of 25 mM NH~4~HCO~3~ and centrifuged as above. The two flow-through were combined, desalted on an Empore C-18 Standard Density Solid-Phase Extraction Cartridge (bed I.D. 7 mm, volume 3 mL; Sigma-Aldrich, United States) and concentrated by vacuum centrifugation, followed by reconstituting the peptides in 40 μL of 0.1% (v/v) formic acid. Peptide quantification was performed by measuring the absorbance at 280 nm on an ultraviolet-visible spectrophotometer.

Liquid Chromatography (LC)-MS/MS Analysis {#S2.SS4}
-----------------------------------------

Proteomic analysis was performed on an Easy-nLC 1,000 System (Thermo Fisher Scientific, United States) coupled to a Q Exactive HF Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific, United States). Each peptide sample was loaded onto an Acclaim PepMap100 C18 reverse-phase trap column (100 μm × 2 cm, nanoViper fitting; Thermo Fisher Scientific, United States) connected to an Easy C18 reverse-phase analytical column (75 μm × 10 cm, 3 μm resin; Thermo Fisher Scientific, United States) pre-equilibrated in buffer A \[0.1% (v/v) formic acid\]. The peptides were separated with a linear gradient of buffer B \[84% (v/v) acetonitrile and 0.1% (v/v) formic acid\] at a constant flow rate of 300 nL/min. The gradient of B was first increased from 0 to 55% over 110 min, then to 100% over 5 min, before being maintained at 100% for another 5 min.

Following the separation, the eluted peptides were immediately analyzed under positive-ion mode with peptide recognition enabled. The ions were first subjected to one survey scan in the m/z range of 300--1,800 at a mass resolution of 70,000 at m/z 200. Automatic gain control target, maximum inject time and dynamic exclusion were set to 3 × 10^6^, 10 ms and 40.0 s, respectively. MS2 spectra were obtained by using a data-dependent top 10 method to dynamically select the most abundant precursor ions from the survey scans for high-energy collisional dissociation (HCD) fragmentation. The resolution of the MS2 scans was set to 17,500 at m/z 200. Isolation width, normalized collision energy and underfill ratio were set to 2 m/z, 30 eV and 0.1%, respectively.

Protein Identification and Quantification {#S2.SS5}
-----------------------------------------

The raw mass spectrometry (MS) data for each sample were combined and imported into MaxQuant (version 1.5.3.17, Max Planck Institute of Biochemistry, Germany) ([@B7]). For protein identification, the MS data were searched against the Uniprot *E. coli* protein database represented by the file uniprot\_*Escherichia_coli*\_1124415_20180910.fasta. Software settings were adjusted as follows: enzyme-trypsin; max missed cleavage-2; fixed modification-carbamidomethyl (C); variable modification-oxidation (M), acetyl (Protein N-term); main search ppm-6; MS/MS tolerance ppm-20; database pattern-reverse; include contaminants-true; false discovery rate (FDR) threshold-0.01; peptides for quantification-unique + razor; match between runs-2 min; protein quantification-label-free quantification (LFQ) ([@B6]); minimum ratio count-1.

Protein quantification was performed based on the LFQ algorithm as previously described ([@B6]; [@B30]). Intensity-based absolute quantification (iBAQ) in MaxQuant was performed on the identified peptides to quantify protein abundance. The significance of the differentially expressed proteins between the samples was examined with the cutoff values fold change \>1.5 and *p* ≤ 0.05 by *t*-test.

Bioinformatics Analysis {#S2.SS6}
-----------------------

For gene ontology (GO^[1](#footnote1){ref-type="fn"}^) analysis, the sequences of differentially expressed proteins were batch-searched against a local SwissProt *E. coli* protein database using the NCBI BLAST + client software (version 2.2.28) to identify any functionally annotated homologs. These annotations were then transferred and combined with those of the corresponding query *E. coli* proteins. To reduce the workload, only the top 10 blast hits of each query sequence with an E-value below 1 × 10^--3^ were selected. These candidates were annotated by Blast2GO (version 3.3.5; [@B61]) with an E-value filter of 1 × 10^--6^, GO weight of 5, annotation cutoff of 75, and default gradual EC weights. Sequences that could not be annotated under these settings were then subjected a new round of annotation using more permissive parameters. Subsequently, the sequences that could not be annotated and those without BLAST hits were then searched against database by using InterProScan ([@B62]) to retrieve functional annotations of their conserved motifs. The combined GO annotation results were plotted by R scripts. For Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation, the sequences of differentially expressed proteins were searched via BLAST against the KEGG Database at <https://www.genome.jp/kegg/kaas> ([@B44]).

Next, enrichment analyses were conducted using Fisher's exact test in order to unearth the cellular and physiological roles of the differentially expressed proteins. The GO terms were categorized into three subcategories, including biological process, molecular function and cellular component. The Benjamini--Hochberg method was used to calculate the adjusted *p*-values. *p* \< 0.05 was considered statistically significant.

Hierarchical Clustering {#S2.SS7}
-----------------------

Hierarchical clustering was performed to reveal global differences in protein expression profiles between the PEF treatment group and the control group. To this end, the data from protein relative expression were analyzed by Cluster 3.0 ([@B36]) using the average-linkage method for clustering, with similarity between genes expressed in Euclidean distance. The obtained dendrogram was visualized in Java Treeview (version 3.0) ([@B81]). In addition, a heat map was also generated as a visual aid.

Protein-Protein Interaction (PPI) Network {#S2.SS8}
-----------------------------------------

The differentially expressed proteins were imported into STRING to analyze their potential interactions (version 10.5) ([@B80]). The results were downloaded in XGMML format and visualized in the form of an interaction network by importing into Cytoscape (version 3.2.1) ([@B81]). The degree value of each protein node was calculated to evaluate its importance in the PPI network.

Parallel Reaction Monitoring (PRM) Analysis {#S2.SS9}
-------------------------------------------

Parallel reaction monitoring analysis of selected proteins were conducted as previously described ([@B53]). Briefly, digested peptides were prepared as elucidated above. Then, 2 μg of the peptides were spiked with 20 fmol standard (PRTC: GISNEGQNASIK) and separated on an Easy nLC 1,200 System (Thermo Fisher Scientific, United States) with the same buffer A, B and flow rate as above. The gradient of B was set as follows: 5--10% over 2 min, 10--30% over 43 min, 30--100% over 10 min and then 100% for another 5 min. The eluted peptides were immediately analyzed under positive-ion mode on a Q-Exactive HF mass spectrometer (Thermo Fisher Scientific, United States). The ions were first subjected to one survey scan in the m/z range of 300 to 1,800 at a mass resolution of 60,000 at m/z 200. Automatic gain control target and maximum inject time were set to 3 × 10^6^ and 200 ms, respectively. The full MS1 scan were followed by 20 MS2 scans at a resolution of 17,500 at m/z 200 ([@B31]). Precursor ions were fragmented via the HCD method at normalized collision energy of 27 eV. Isolation window and maximum injection time were set to 1.6 Th and 120 ms, respectively. The obtained raw PRM data were imported into Skyline (version 3.5.0) ([@B39]) for analysis.

Quantitative Reverse-Transcription Polymerase Chain Reaction (qRT-PCR) Analysis {#S2.SS10}
-------------------------------------------------------------------------------

Following the PEF treatment, total RNA was immediately extracted using anRNAiso Plus Kit (TaKaRa, Japan), followed by reverse transcription with a PrimeScript Reverse Transcriptase Kit (TaKaRa, Japan). All gene-specific primers were designed using Primer Premier 5.0 software (Premier Biosoft International, United States) and synthesized by Sangon Biotech, China. Gene expression levels were analyzed by qRT-PCR using SYBR Green qPCR Mix (TaKaRa, United States) on a CFX96 Real-Time PCR System (Bio-Rad, United States) according to the manufacturers' instructions. Glucan biosynthesis protein G (mdoG) was used as a control ([@B20]). All reactions were performed with at least three replicates. Fold changes were calculated based on the 2^--ΔΔ^*^*Ct*^* method ([@B51]).

Statistical Analysis {#S2.SS11}
--------------------

All statistical analyses were performed using the SPSS software (version 13.0; IBM, United States). Data were expressed as mean ± standard error of mean (SEM). Differences between two groups were analyzed using Student's *t*-test. *p* \< 0.05 was considered statistically significant.

Results {#S3}
=======

Protein Identification and Differential Expression Analysis {#S3.SS1}
-----------------------------------------------------------

We used an untargeted LC-MS/MS approach to systematically investigate the effects of PEF on *E. coli* proteome. To this end, we applied PEF to freshly grown *E. coli* cells under abovementioned conditions that resulted in a 95 ± 2.0% reduction of bacterial population. In the meantime, we set up a control group in which cell aliquots from the same culture were similarly processed, but without the application of PEF. In total, we detected 16,829 peptides from our MS data and identified 2,252 proteins by sequence comparison with the Uniprot *E. coli* protein database. We then calculated the relative abundances of all identified proteins in the two experimental groups. Comparison of the expression data revealed 123 differentially expressed proteins based on the criteria of fold-change \>1.5 or \<0.67 and *p* \< 0.05. Among them, 99 proteins exhibited significantly increased expression levels in PEF-processed *E. coli*, whereas 24 were found to be down-regulated ([Table 1](#T1){ref-type="table"}). The annotations, accession numbers and fold-change values of all differential proteins were summarized in [Table 1](#T1){ref-type="table"}. Notably, 33 proteins were confidently detected in at least two PEF-treated *E. coli* cultures but not in any of the controls, whereas another 19 were identified in at least two control samples but showed no apparent expression in the PEF treatment group. These candidates were therefore also considered as differentially expressed between the two groups and subsequently merged with the 123 proteins mentioned above. It is worth emphasizing that the reason that some proteins were only detected in two of the three samples in an experimental group could be caused by a combination of biochemical, analytical and statistical factors, such as miscleavage, ionization competition, ion suppression, peptide misidentification, ambiguous matching, etc. ([@B25]).

###### 

The significantly upregulated and downregulated proteins in *E. coli* after PEF-treated.

  **Accession**   **Description**                                                                                                  **Coverage**   **Unique peptides**   **Folds Exe/Con**   ***p*-value**
  --------------- ---------------------------------------------------------------------------------------------------------------- -------------- --------------------- ------------------- ---------------
  M9GK20          Citrate synthase, GN=ECMP0215612_0833                                                                            60.9           20                    181.5173            0.0277
  A0A0H3JNL0      Putative glucarate dehydratase, GN=ECs3648                                                                       5              1                     28.3712             0.0232
  V0UHA6          Octanoyltransferase, GN=lipB                                                                                     35.1           3                     18.3945             0.0002
  W8T6L6          2-methylisocitrate lyase, GN=prpB                                                                                24             1                     15.7546             0.0040
  A0A2B7LUZ2      Aconitate hydratase B, GN=BMR23_08950                                                                            73.8           0                     12.0020             0.0275
  M9FZM4          2-methylcitrate dehydratase, GN=prpD                                                                             48.4           16                    7.4411              0.02615
  A0A0G3K113      Bifunctional protein PutA, GN=putA                                                                               49.8           1                     5.9676              0.0224
  W1G3P2          Aldehyde-alcohol dehydrogenase                                                                                   53.6           1                     5.8303              0.0452
  W8ZMF2          Putative resistance protein, GN=yggT                                                                             10.1           2                     4.0885              0.0211
  A0A0K5XJK9      Ribosomal RNA small subunit methyltransferase F, GN=rsmF                                                         10.1           2                     3.6706              0.0003
  A0A234Q1M9      GTP-binding protein, GN=AL530_011080                                                                             18.3           1                     3.4667              0.0027
  A0A234Y2B9      Putrescine-binding periplasmic protein, GN=RX35_02543                                                            17.3           1                     3.2918              0.0144
  I0VQW1          2-dehydropantoate 2-reductase, GN=ECW26_29640                                                                    13.2           2                     3.2735              0.0249
  I4T327          Tryptophan permease, GN=EC54115_06619                                                                            9.6            3                     3.2120              0.0008
  A0A073V5W9      Dicarboxylate symporter family protein (Fragment), GN=AB08_2087                                                  11.2           3                     3.0766              0.0312
  Q8 × 646        Uncharacterized protein, GN=ECs2348                                                                              56.1           3                     3.0709              0.0023
  A0A2T7Y366      FeS assembly scaffold SufA, GN=sufA                                                                              16.7           1                     2.9581              0.0116
  A0A229AFZ0      Lactam utilization protein LamB, GN=CDL37_20835                                                                  61.4           1                     2.8832              0.0014
  W9AMD8          Phosphate-binding protein PstS, GN=pstS                                                                          50.3           5                     2.8444              0.0023
  W1FRP3          ATP-dependent Clp protease ATP-binding subunit ClpA                                                              34.4           0                     2.7513              0.0314
  W1FTY7          Galactose/methyl galactoside ABC transport system, D-galactose-binding periplasmic protein MglB (TC 3.A.1.2.3)   49.4           1                     2.6992              0.0013
  W1F3 × 3        Phosphate transport ATP-binding protein PstB (TC 3.A.1.7.1)                                                      24.7           5                     2.6913              0.0155
  A0A2H9B301      L-cystinetransporter, GN=CG691_13490                                                                             8.7            2                     2.5515              0.0080
  A0A193RPM2      Ornithine decarboxylase, GN=WM48_15995                                                                           11.3           6                     2.4748              0.0009
  A0A0T5XPP6      Molybdopterin biosynthesis protein MoeA, GN=AOX65_16030                                                          3.2            1                     2.4707              0.0008
  A0A2T8H312      Bifunctional glutamine amidotransferase/anthranilate phosphoribosyltransferase, GN=APX76_17630                   35.3           11                    2.4593              0.0006
  W8SPU9          Nicotinate phosphoribosyltransferase, GN=pncB                                                                    21.2           6                     2.3065              0.0056
  A0A1 × 3L920    Protein AmpE, GN=EAXG_02432                                                                                      14.8           1                     2.2675              0.0084
  D7 × 9F1        Uncharacterized protein (Fragment), GN=HMPREF9552_03278                                                          50             2                     2.2191              0.0032
  W9ADK0          Uncharacterized protein, GN=ycbJ                                                                                 20.2           4                     2.1980              0.0033
  A0A0T5XIP1      Regulator of ribonuclease activity A, GN=rraA                                                                    27.3           1                     2.1974              0.0017
  W9ADR5          Uncharacterized protein, GN=yccJ                                                                                 60             3                     2.1729              0.0246
  W1WSH0          Protein mioC, GN=Q609_ECAC01910G0002                                                                             44.9           3                     2.1698              0.0108
  A0A1 × 3KHH3    Alcohol dehydrogenase YqhD, GN=EATG_01859                                                                        39             1                     2.1604              0.0003
  W8ZNL1          UPF0250 protein YbeD, GN=ybeD                                                                                    55.2           4                     2.1440              0.0009
  A0A096ZJW9      Sigma-38 (Fragment), GN=rpoS                                                                                     38.7           9                     2.1201              0.0050
  V8FHS8          Spermidine/putrescine ABC transporter substrate-binding protein, GN=Q458_15770                                   56.2           15                    2.0609              0.0268
  A0A2B7MPJ0      Dihydroxyacetone kinase subunit DhaM, GN=BMR23_01885                                                             17.4           1                     2.0210              0.0283
  W1 × 9K1        Galactonate operon transcriptional repressor (Fragment), GN=Q609_ECAC00550G0001                                  35             4                     2.0176              0.0017
  W8ZNL8          Nuclease SbcCD subunit C, GN=sbcC                                                                                5.8            4                     2.0107              0.0127
  W8ZJY8          Uncharacterized protein, GN=yecA                                                                                 35.7           5                     2.0036              0.0011
  W8ZVZ2          Sulfate adenylyltransferase subunit 1, GN=cysN                                                                   32.2           12                    2.0004              0.0294
  W9AED4          Fatty acid metabolism regulator protein, GN=fadR                                                                 56.9           10                    1.9864              0.0041
  W8STE3          BolA DNA-binding transcriptional dual regulator, GN=bola                                                         42.3           3                     1.9619              0.0064
  V6FYL6          Bifunctional polymyxin resistance protein ArnA, GN=arnA                                                          25.9           13                    1.9311              0.0075
  A0A0K9TED1      Smgprotein, GN=ERYG_01892                                                                                        45.3           3                     1.8818              0.0119
  W8ZV88          Sulfite reductase \[NADPH\] hemoprotein beta-component, GN=cysI                                                  30.5           6                     1.8737              0.0141
  W1WPC4          Cell division protein ZapB, GN=zapB                                                                              88.6           7                     1.8712              0.0026
  W8T248          Protein YciE, GN=yciE                                                                                            51.8           6                     1.8429              0.0174
  W1HGY9          6,7-dimethyl-8-ribityllumazine synthase, GN=ribH                                                                 87.2           8                     1.8411              0.0024
  A0A2S7HHN4      Uncharacterized protein (Fragment), GN=C5P43_35025                                                               34.2           3                     1.8367              0.0432
  M9GGR7          Protein rof, GN=rof                                                                                              63.3           3                     1.8317              0.0361
  W1F1D7          Anthranilate synthase component 1                                                                                32.5           14                    1.8300              0.0208
  V8KFY8          Protein CsiD, GN=csiD                                                                                            64.6           17                    1.8290              0.0061
  W8ZNY2          Transcriptional regulator ModE, GN=modE                                                                          51.9           8                     1.8284              0.0121
  D6I850          YciFprotein, GN=ECDG_01154                                                                                       45.2           6                     1.8177              0.0022
  V0YAU0          Uncharacterized protein (Fragment), GN=HMPREF1608_01019                                                          24.2           1                     1.8173              0.0434
  A0A0K4H5N9      Transcriptional regulator, GN=ERS085411_00773                                                                    27.4           10                    1.7957              0.0022
  V0YHQ2          DNA recombination protein RmuC, GN=HMPREF1608_02578                                                              20.6           8                     1.7851              0.0374
  A0A1 × 1LNA3    Formate dehydrogenase-N subunit alpha, GN=fdnG                                                                   41.6           30                    1.7653              0.0156
  V6FUE1          Pimeloyl-\[acyl-carrier protein\] methyl ester esterase, GN=bioH                                                 30.1           4                     1.7541              0.0492
  W8U272          Fused mannitol-specific PTS enzymes: IIA components/IIB components/IIC components, GN=mtlA                       36.1           14                    1.7486              0.0103
  A0A1 × 3KKE8    Transketolase, GN=EATG_02582                                                                                     37.5           1                     1.7098              0.0264
  W8ZZB2          Regulator of ribonuclease activity A, GN=menG                                                                    50.3           4                     1.7003              0.0006
  W8ZPR2          Protein TusB, GN=yheL                                                                                            12.6           1                     1.6993              0.0332
  S0VE10          PTS system trehalose-specific EIIBC component, GN=WE7_05383                                                      18.4           6                     1.6949              0.0410
  W8TSM7          C-lysozyme inhibitor, GN=ivy                                                                                     46.6           5                     1.6947              0.0206
  W9AP24          Regulator of ribonuclease activity B, GN=yjgD                                                                    39.1           3                     1.6871              0.0056
  W8ZR12          Tryptophan synthase alpha chain, GN=trpA                                                                         59.7           1                     1.6803              0.0021
  W1EYP8          L-proline glycine betaine ABC transport system permease protein ProW (TC 3.A.1.12.1)                             16.2           2                     1.6793              0.0206
  W8U2G6          Carboxymethylenebutenolidase, GN=ysgA                                                                            38             5                     1.6667              0.0317
  W8ZZG4          Regulator of sigma D, GN=yjaE                                                                                    27.8           3                     1.6666              0.0034
  A0A0T5XE89      Threonine synthase, GN=AOX65_13005                                                                               13.1           1                     1.6576              0.0007
  T9DJA4          Glutaminase, GN=glsA                                                                                             48.4           3                     1.6534              0.0071
  W1 × 6R0        Phosphate starvation-inducible protein psiF, GN=Q609_ECAC01403G0002                                              39.6           4                     1.6472              0.0342
  W8ZRC1          Uncharacterized protein, GN=EC958_1708                                                                           73             12                    1.6406              0.0150
  A0A2H9CSQ5      Deoxyuridine 5-triphosphate nucleotidohydrolase, GN=coaBC                                                        45.9           15                    1.6347              0.0003
  W1EQP2          Tryptophan synthase beta chain, GN=trpB                                                                          38.8           2                     1.6319              0.0017
  A0A0J2EWU6      Dihydroorotate dehydrogenase (quinone), GN=pyrD                                                                  36             9                     1.6316              0.0007
  W1EWD5          Transcriptional regulator YcjW, LacI family, possibly involved in maltodextrin utilization pathway               15.9           1                     1.6275              0.0138
  W9AB69          Uridylatekinase, GN=pyrH                                                                                         45.2           7                     1.6140              0.0320
  W8ZNI9          Regulator of nucleoside diphosphate kinase, GN=rnk                                                               26.5           2                     1.6051              0.0140
  S1J5S6          Protein AroM, GN=A1WS_00874                                                                                      16             1                     1.6048              0.0490
  W1XC14          Iron-sulfur cluster insertion protein ErpA, GN=erpA                                                              22.8           2                     1.5893              0.0095
  U9YVN3          D-methionine-binding lipoprotein MetQ, GN=HMPREF1599_05823                                                       20.2           2                     1.5838              0.0117
  W1VVN8          Replicative DNA helicase, GN=Q609_ECAC02906G0004                                                                 25.3           8                     1.5828              0.0111
  A0A2A3VGN6      UDP-4-amino-4-deoxy-L-arabinose -- oxoglutarate aminotransferase, GN=arnB                                        20.3           2                     1.5763              0.0295
  H4UMP9          Inner membrane protein ypjD, GN=ypjD                                                                             8.2            1                     1.5698              0.0065
  W1F6U7          Chromosome partition protein MukE, GN=mukE                                                                       37.3           6                     1.5425              0.0203
  W8SQ29          GST-like protein with glutathione S-transferase domain protein YliJ, GN=gstB                                     52.4           8                     1.5391              0.0072
  A0A2I6JDE7      Arabinose ABC transporter substrate-binding protein, GN=CRT55_12445                                              32             2                     1.5267              0.0465
  W8SS44          Hydrolase, GN=ycaC                                                                                               48.6           3                     1.5255              0.0104
  W1EY44          Zinc transport protein ZntB                                                                                      13.4           3                     1.5160              0.0148
  W8ZUR8          Uncharacterized protein, GN=elaB                                                                                 44.6           4                     1.5169              0.0186
  H4LI45          Peptidyl-prolyl *cis*-*trans* isomerase, GN=slyD                                                                 68             6                     1.5151              0.0356
  W1WTW0          Arginine repressor, GN=argR                                                                                      42.9           4                     1.5101              0.0013
  V2T0T4          ABC transporter periplasmic-binding protein, GN=G723_01103                                                       17.6           5                     1.5076              0.0307
  A0A2R9W5R2      Primosomal protein DnaT (Fragment), GN=C1I57_22015                                                               33.6           3                     1.5058              0.0426
  A0A2R9W0 × 1    L-arabinose isomerase (Fragment), GN=C1I57_30235                                                                 10.6           3                     1.5021              0.0302
  W8ZM76          Uncharacterized protein, GN=yadG                                                                                 19.2           7                     0.6651              0.0173
  W8ZVN7          Putative YhbH sigma 54 modulator, GN=EC958_2900                                                                  59.3           6                     0.6611              0.0349
  M9FWG9          Arginine transport ATP-binding protein ArtP, GN=artP                                                             23.1           4                     0.6609              0.0215
  W9ACD0          Proofreading thioesterase EntH, GN=ybdB                                                                          18.2           2                     0.6451              0.0007
  A0A0A0FBI3      Uncharacterized protein, GN=EL76_3316                                                                            16             1                     0.6406              0.0041
  W8ZQK0          Protoporphyrinogen oxidase, GN=hemG                                                                              30.4           5                     0.6399              0.0391
  T6MLM8          DNA polymerase, GN=G749_00151                                                                                    0.9            1                     0.6373              0.0079
  W1W6N1          1,4-dihydroxy-2-naphthoate octaprenyltransferase, GN=menA                                                        6.5            2                     0.6348              0.0084
  E5FGE1          WeiT, GN=weiT                                                                                                    21.8           7                     0.6195              0.0005
  W9AKV1          Uncharacterized protein, GN=yrdD                                                                                 13.3           2                     0.6191              0.0053
  W9AHV7          Anaerobic glycerol-3-phosphate dehydrogenase subunit C, GN=glpC                                                  18.4           7                     0.6148              0.0308
  I0VVR9          Nitrite reductase (NAD(P)H), large subunit, GN=ECW26_12260                                                       10.9           9                     0.6079              0.0023
  A0A2S7H9V9      Phosphate acyltransferase PlsX (Fragment), GN=plsX                                                               10.1           2                     0.6067              0.0152
  W1WWC3          Outer membrane lipoprotein Blc, GN=Q609_ECAC01725G0007                                                           11.5           2                     0.6030              0.0401
  G0F3L2          Polyketide cyclase/dehydrase and lipid transport family protein, GN=UMNF18_3418                                  42.6           5                     0.6011              0.0032
  V0SC60          Uncharacterized protein, GN=HMPREF1595_04697                                                                     43.4           7                     0.6010              0.0207
  W9AKX1          50S ribosomal protein L30, GN=rpmD                                                                               57.6           4                     0.6008              0.0219
  W1F1V3          CDP-diacylglycerol pyrophosphatase, GN=cdh                                                                       25.1           6                     0.5951              0.0127
  W8ZP35          Uncharacterized protein, N=yqjE                                                                                  20.9           4                     0.5847              0.0081
  W1WR46          Inner membrane protein ylaC, GN=Q609_ECAC01779G0002                                                              43.6           6                     0.5658              0.0010
  A7ZI09          Uncharacterized protein, GN=EcE24377A_0284                                                                       11             2                     0.5396              0.0048
  W1WXG0          Uncharacterized protein, GN=Q609_ECAC01601G0009                                                                  52.7           5                     0.5229              0.0006
  W8ZSI0          Cyclopropane fatty acyl phospholipid synthase, GN=EC958_1883                                                     34.6           11                    0.4375              0.0019
  A0A1V2T523      DeoR family transcriptional regulator (Fragment), GN=BET08_18455                                                 7.9            2                     0.1134              0.0018

To better compare the global proteomic profiles of the PEF-treated *E. coli* samples and the controls, we performed hierarchical clustering analysis of the 123 differentially expressed proteins and illustrated the results in an expression heat map with dendrogram ([Figure 2](#F2){ref-type="fig"}). As depicted, the plot indicated clear differences in the number of detected proteins between the two experimental groups.

![Hierarchical clustering of 123 differentially expressed proteins (confidently detected in all six samples; fold-change \>1.5 or \<0.67, and *p* \< 0.05; see [Table 1](#T1){ref-type="table"}). Results are illustrated using a heat map with a dendrogram. The Uniprot ID of each protein is listed in the column to the right of the heat map. The color bar located below the heat map denotes the extent of change in expression level, with red indicating up-regulation and blue down-regulation.](fmicb-10-02644-g002){#F2}

Functional Analysis of the Differentially Expressed Proteins {#S3.SS2}
------------------------------------------------------------

We next performed functional analysis of all 175 differentially expressed proteins (including the ones that could not be confidently detected in all samples as explained above) to shed light on their potential molecular and cellular roles. GO annotation by Blast2GO and InterProScan indicated that the differential proteins were predominantly involved in catalytic activity (47.43%) and binding (38.86%) under the subcategory of molecular function ([Figure 3A](#F3){ref-type="fig"}). For biological process, the overwhelming majority of the candidates could be assigned to GO terms of cellular process (36%) and metabolic process (38.29%) ([Figure 3A](#F3){ref-type="fig"}). Subsequent GO enrichment analysis demonstrated that PEF-treated *E. coli* underwent a wide range of metabolic alterations, such as those associated with sulfate, sulfide, propionate, 2-methylcitrate and short-chain fatty acids. In addition, we also identified significant changes in the transmembrane transport of inorganic anions, particularly phosphate ions. Other notably enriched GO terms included enzyme binding and enzyme inhibitor activity, including ribonuclease inhibitor activity, endoribonuclease inhibitor activity and methyl isocitrate lyase activity ([Figure 3B](#F3){ref-type="fig"}).

![Gene ontology (GO) annotation and enrichment analysis of all 175 differentially expressed proteins. **(A)** The primary *Y* axis denotes the number of annotated proteins categorized to each GO term. The secondary *Y* axis represents the percentage of annotated proteins belonging to each GO term in all differential proteins. GO terms are classified into three subcategories, including biological process (BP, red), molecular function (MF, purple) and, cellular compartment (CC, orange). **(B)** The color gradient from orange to red represents the *p*-value; the closer the color to red, the lower the *p*-value and the higher the significance level corresponding to the enrichment. The small number above each column is the rich factor, which denotes the ratio of the number of differential proteins enriched to a given GO term to the number of all annotated proteins categorized to the same GO term.](fmicb-10-02644-g003){#F3}

On the other hand, the differentially expressed proteins could be mapped to 81 KEGG pathways. The top 5 KEGG pathways with the greatest numbers of protein candidates included those associated with ABC transporters, two-component system, propanoate metabolism, phenylalanine, tyrosine and tryptophan biosynthesis, as well as sulfur metabolism ([Figure 4A](#F4){ref-type="fig"}). Further examination suggested that sulfur metabolism was significantly enriched ([Figure 4B](#F4){ref-type="fig"}), which comprised four differentially expressed proteins W8ZVZ2 (sulfate adenylyltransferase subunit 1, EC:2.7.7.4, CysND), W8ZV88 (Sulfite reductase \[NADPH\] hemoprotein beta-component, EC:1.8.1.2, CysJI), I0VXI2 (Sulfate-binding protein, CysPUWA) and A0A1V2T430 \[Adenylyl-sulfate kinase (Fragment), EC:2.7.1.25, CysC\]. Among them, W8ZVZ2 and W8ZV88 were up-regulated in PEF-treated *E. coli* cells by 2.0-fold and 1.8-fold, respectively, compared to the untreated cells, whereas I0VXI2 and A0A1V2T430 were only detected in PEF-treated cells. The metabolic roles of these proteins were illustrated in [Figure 4C](#F4){ref-type="fig"}.

![KEGG pathway and enrichment analysis of all 175 differentially expressed proteins. **(A)** The *Y* axis indicates the number of annotated proteins that are categorized into each KEGG pathway. Only the top 20 pathways are shown. **(B)** Sulfur metabolism is the only KEGG pathway found to be significantly enriched. **(C)** An illustration of the cellular processes associated with sulfur metabolism pathways. All differential proteins captured in this study are highlighted in red. Small circles (o) represent small-molecule metabolites (Source: [@B22]).](fmicb-10-02644-g004){#F4}

PPI Analysis {#S3.SS3}
------------

It is a well-established concept that cellular processes are often the results of specific interactions between two or more proteins rather than the actions of a single protein. Based on these considerations, we constructed a PPI network of all the differentially expressed proteins that we identified in order to gain a deeper understanding of how the various PEF-altered biological functions in *E. coli* cells were interconnected with each other. As shown in [Figure 5](#F5){ref-type="fig"}, the network map comprised 123 nodes and 208 interactions. W8ZUR8 (uncharacterized protein elaB), predicted by GO annotation to participate in ribosome binding, represented the largest node with ten putative associations. Other differential proteins predicted to interact with seven or more partners included W9ADR5 (uncharacterized protein yccJ), W9ADK0 (uncharacterized protein cbJ), A0A1 × 3L920 (beta-lactamase induction protein AmpE), W8SS44 (hydrolase ycaC), W8ZR12 (tryptophan synthase alpha chain, trpA), and V6FUM8 (universal stress protein B UspB). Notably, all these proteins were up-regulated in the PEF treatment group, with V6FUM8 detected only in PEF-processed samples.

![PPI network based on 124 proteins from all 175 differentially expressed proteins. Nodes and lines represent the protein and their interactions, respectively.](fmicb-10-02644-g005){#F5}

Data Verification by PRM Analysis {#S3.SS4}
---------------------------------

The proteomic data were verified by selecting five differentially expressed proteins for PRM analysis, including M9GK20 (Citrate synthase), W8ZVZ2 (Sulfate adenylyltransferase subunit 1), V6FYL6 (Bifunctional polymyxin resistance protein ArnA), M9FZM4 (2-methylcitrate dehydratase) and W9AMD8 (Phosphate-binding protein PstS). We quantified the levels of 1--3 unique peptides for each selected protein in the PEF-processed *E. coli* and untreated controls. As shown in ([Table 2](#T2){ref-type="table"}), all five proteins were significantly up-regulated as a result of the PEF treatment, which was consistent with the results of the untargeted proteomic analysis. This suggested that the proteomic data that we obtained were sufficiently reliable for subsequent interpretation.

###### 

Comparison of quantification results between label-free and PRM.

  **Accession**   **Description**                                  **PRM results**   **Label-free results**
  --------------- ------------------------------------------------ ----------------- ------------------------
  M9GK20          Citrate synthase                                 6.96 (up)         181.5172 (up)
  W9AMD8          Phosphate-binding protein                        3.60 (up)         2.8444 (up)
  M9FZM4          2-methylcitrate dehydratase                      7.32 (up)         7.4411 (up)
  V6FYL6          Bifunctional polymyxin resistance protein ArnA   1.55 (up)         1.9311 (up)
  W8ZVZ2          Sulfate adenylyltransferase subunit 1            1.87 (up)         2.0004 (up)

In the present study, we systematically analyzed PEF-induced changes in the protein expression profile of *E. coli* through MS-based label-free quantitative proteomics. Our experimental data echoed previous findings ([@B55]; [@B77]; [@B79]), that exposure to PEF exerted significant detrimental effects on cell membrane integrity, triggered a host of cellular stress response mechanisms, and altered important metabolic pathways. The results of our current study could increase our understanding of the mechanisms responsible for PEF-induced inactivation of bacterial cells in food products.

qRT-PCR Validation {#S3.SS5}
------------------

We selected a list of significantly up-regulated proteins and measured their mRNA levels at different PEF intensities (which resulted in different cell killing levels). The detailed information and the selection rationale for each protein were summarized in ([Table 3](#T3){ref-type="table"}). As illustrated in [Figure 6](#F6){ref-type="fig"}, all candidates demonstrated increased transcription at all PEF intensities that we tested, confirming the validity of our proteomic results. However, the genes showed different expression trends with increasing PEF intensities. In most cases, we did not observe a positive correlation between the mRNA level of the gene and the level of cell death. These results suggested that PEF treatment could directly stimulate the expression of the *E. coli* proteins, though indirect contribution via cell lysis could not be completely eliminated. In addition, at high intensities, PEF exerted a clear inhibitory effect on the transcription of most of the genes.

###### 

Differential protein use for fluorescence quantification PCR.

  **Protein**    **Gene Name**   **Reason for verification**
  -------------- --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------
  M9GK20         prpC            Transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer, tricarboxylic acid cycle
  W9AMD8         pstS            Part of the ABC transporter complex PstSACB involved in phosphate import
  M9FZM4         prpD            Propionate catabolic process, 2-methylcitrate cycle
  W8ZMF2         yggT            Resistance protein
  ECs3648        A0A0H3JNL0      Amino acid metabolism
  V0UHA6         lipB            Catalyzes the transfer of endogenously produced octanoic acid from octanoyl-acyl-carrier-protein onto the lipoyl domains of lipoate-dependent enzymes.
  W8T6L6         prpB            Catalyzes the thermodynamically favored C-C bond cleavage of (2R,3S)-2-methylisocitrate to yield pyruvate and succinate.
  W8ZVZ2         cysND           Sulfur metabolism
  V6FYL6         arnA            The modified arabinose is attached to lipid A and is required for resistance to polymyxin and cationic antimicrobial peptides.
  V6FUM8         uspB            Universal stress protein
  W8ZUR8         elaB            Ribosome binding
  A0A1 × 3L920   AmpE            PPI network important node
  W9ADK8         ompF            Outer membrane protein

![The effect of PEF treatment on the expression of selected *E. coli* genes under different pulse conditions (^∗^*p* \< 0.05, ^∗∗^*p* \< 0.01, ^∗∗∗^*p* \< 0.001). The gene expression data are arranged in separate column charts due the fold-change values of pstS being significantly greater than those of other genes. The pulse conditions and cell killing extent for each sample are as follows: control sample: untreated; PEF-treated sample 1: pulse intensity -- 2.88 kV cm^--1^, pulse number -- 62, pulse duration -- 82 μs, cell killing extent -- 29 ± 0.7%; PEF-treated sample 2: pulse intensity -- 6.10 kV cm^--1^, pulse number -- 54, pulse duration -- 77 μs, cell killing extent -- 51 ± 1.3%; PEF-treated sample 3: pulse intensity -- 14.5 kV cm^--1^, pulse number -- 26, pulse duration -- 67 μs, cell killing extent -- 95 ± 2.0%.](fmicb-10-02644-g006){#F6}

Discussion {#S4}
==========

Notable among the most up-regulated proteins in the PEF treatment group are several enzymes related to the methylcitrate cycle and the TCA cycle, including 2-methylisocitrate lyase (PrpB; W8T6L6), the dual-functional aconitate hydratase B (alsoaconitase, AcnB; A0A2B7LUZ2), 2-methylcitrate dehydratase (PrpD; M9FZM4), and the rate-limiting citrate synthase (prpC; M9GK20). The methylcitrate cycle functions in a similar manner as the TCA cycle, and is responsible for converting propionyl-CoA to pyruvate for further catabolism ([@B37]; [@B56]). As a result, both the TCA cycle and the methylcitrate cycle are functionally connected to and downstream of the β-oxidation of fatty acids. Since increased lipid oxidation is a well-established phenomenon under oxidative stress ([@B11]) or PEF treatment ([@B23]; [@B77]), we speculate that the augmented expression of TCA or methylcitrate cycle-associated enzymes could reflect a pre-emptive metabolic defense mechanism of the stressed *E. coli* cells. This is supported by the results discussed in several studies with regard to the anti-oxidative roles of the TCA cycle ([@B68]; [@B40]). It is worth mentioning that AcnB contains a critical Fe-S cluster that is particularly susceptible to oxidative stress. In fact, there is evidence that excessive accumulation of reactive oxygen species (ROS) could dramatically reduce the protein level of AcnB in superoxide dismutase-deficient *Salmonella enterica* ([@B65]). Therefore, the effects of PEF treatment and oxidative stress on the expression of AcnB and other enzymes mentioned above could be both stimulatory and inhibitory. Another top-ranking up-regulated enzyme is bifunctional proline utilization A (PutA; A0A0G3K113), which catalyzes the conversion of proline to glutamate via two consecutive steps of dehydrogenation ([@B42]). PutA is known to be involved in redox homeostasis and its deletion in *E. coli* has been shown to substantially increased cell susceptibility to oxidative injuries ([@B78]). It has been postulated that the protective role of PutA against oxidative stress could be attributed to the generation of a low level of hydrogen peroxide by proline oxidative metabolism, which builds resistance in cells in a pre-adaptive manner ([@B78]). Taken together, these results suggested that PEF treatment and the possibly associated oxidative stress could activate the stress response mechanism in the *E. coli* cells, leading to induced expression of various oxidation-combating enzymes.

Cell membrane functions as the main barrier against harmful substances and regulates the exchange of essential materials between the cytoplasm and the environment. When exposed to a strong electric field, a cell becomes polarized due to the migration of ions in its cytoplasmic fluid. The realignment of opposite charges on both sides of the cell creates electrostatic attraction that squeezes the cell and its membrane ([@B82]). Meanwhile, the various membrane constituents of the cell are also perturbed by the electromechanical forces. The polar lipids, including phospholipids and cholesterol, represent obvious targets. As the electric field intensifies, both electromechanical compression and polar lipid rearrangement will reach a breaking point that leads to pore formation ([@B82]; [@B57]; [@B72]; [@B71]; [@B33]). One of the direct consequences of this is increased membrane permeability, which not only allows entry of deleterious substances, but also generates an osmotic imbalance ([@B1]). Obviously, the electric induction of a few small pores is usually non-lethal, as the fluidity of the biolipid layer allows rapid restoration of a stable membrane structure ([@B1]). However, a sufficiently strong electric field is capable of creating an increased number of large pores on the membrane, leading to irreversible cell damage, disruption, and eventually death ([@B35]; [@B29]). Numerous studies have been performed to determine the boundary between PEF-induced temporary electroporation and permanent sterilization. Based on these results, it is generally believed that irreversible cell injury occurs when the field strength reaches 5--15 kV⋅cm^--1^ ([@B15]). This is consistent with observations that PEF at an intensity above 15 kV⋅cm^--1^ is necessary for membrane breakdown ([@B24]; [@B26]). However, some researchers have noticed microbial resistance to field strengths as high as 19 kV⋅cm^--1^ ([@B70]). As a result, it has been argued that PEF with a field strength of 25 kV⋅cm^--1^ or above should be used to ensure pathogen inactivation in food processing ([@B67]).

Overall, 29 of the 175 differentially expressed proteins that we identified in our current proteomic study are localized on the cell membrane and/or potentially involved in membrane functions. Particularly, 16 of these proteins participate in the transmembrane transport of various small metabolites and macromolecules, including phosphate ions, zinc, glycine betaine, trehalose, as well as short peptides, carbohydrates and lipids in general. There is ample evidence that sugar molecules, especially trehalose, exert a protective effect on the physical structure and integrity of cell membrane ([@B9]). It has been hypothesized that carbohydrates can increase the internal cohesion of cell membrane by forming stabilizing hydrogen bonds with its various components ([@B35]). Another theory argues that sucrose and trehalose can mitigate mechanical disruption of cell membrane by forming an amorphous glass structure ([@B8]). In support of these roles, Pereira et al. demonstrated that trehalose could effectively reduce the physical stress that stretching induced on cell membrane by forming hydrogen bonds with the polar lipid components ([@B50]). Glycine betaine is another well-known cryoprotectant and osmoprotectant that is often accumulated in cells in response to external abiotic stress stimuli. Several studies have shown that transport of glycine betaine across bacterial cell membrane can be activated by osmotic shock and low temperature ([@B13]; [@B16]). Therefore, it seems more plausible that the altered expression of membrane transporters could be a cellular defense mechanism against PEF-induced structural disruptions, though it is also possible that the electromechanical forces might directly affect the expression or stability of these proteins.

It is worth mentioning that some of the differential membrane proteins were only detectable in the PEF treatment group. A careful survey of their functions implied that these proteins might have been activated by PEF for different reasons. The outer membrane protein F (ompF; W9ADK8) directly contributes to pore formation and has been shown to help *E. coli* cells maintain their structural stability ([@B47]). However, the effects of ompF seem to be mixed, as [@B63] reported that its deletion led to substantial enhancement of membrane integrity. Based on these findings, we speculated that the augmented expression of ompF could either be a sign of increased membrane damage or reflect the cellular response to PEF-induced perturbations of intracellular compounds. Universal stress protein B (uspB; V6FUM8) and other members of the USP family can be induced by a wide range of abiotic stress stimuli ([@B45]) and participate in a variety of cytoprotective activities such as DNA protection ([@B18]), arrest of cell growth ([@B46]) and re-adaptation of cell metabolism to nutrient shortage ([@B66]). The *E. coli* sensor histidine kinase (A0A2R9W207) belongs to the two-component signal-transducing system implicated in stimuli perception ([@B41]). Thus, its stimulated expression could be the result of increased PEF-dependent stresses. The prenyltransferase family protein (ubiA; A0A080HYZ5) is responsible for lipidating a wide range of suitable acceptor compounds. Recent studies pointed out that many lipophilic products of prenyltransferase serve as important components of bacterial cell membrane ([@B28]), raising the possibility that its up-regulation by PEF could be a cellular repair mechanism. We are especially intrigued to discover that a macrolide-specific efflux protein (MacA; H4L9U9) exhibited detectable expression only in PEF-treated cells. Mostly known for their antibiotic activities, macrolides are recently speculated to play an additional role in membrane organization. For example, [@B69] examined the mechanism of azithromycin-based inhibition of endocytosis and found that the macrolide compound could diminish membrane fluidity by binding to the polar heads of phospholipids. This is further corroborated by findings that macrolide efflux pumps can be up-regulated by stress signals unrelated to drug resistance ([@B2]).

In addition to [@B55] protein profiling study based on 2D gel electrophoresis, there have been several other proteomics or transcriptomics investigations of PEF-treated *E. coli*. Chueca and coworkers treated *E. coli* MG1655 cells, buffered at pH 4.0, with 50 exponential waveform electric pulses with a frequency of 0.08 Hz and pulse duration of 2 μs, followed by DNA microarray-based transcriptomic analysis ([@B4]). Based on their data, a total of 47 genes showed differential expression as a result of the treatment. One of their major findings was the significantly elevated mRNA expression of several genes associated with the TCA cycle, including (*sdhA*, *sdhB*, *sdhC*, *sdhD*). Although these genes were different from those that encoded the differential proteins identified in this study, their finding of a link between PEF treatment and alterations in TCA-associated cell metabolism mirrored what our results unearthed in this study. In addition, [@B4] study also indicated the up-regulation of genes involved in cell respiration and membrane function, as well as the down-regulation of several mRNAs related to acid shock response, possibly as a result of the mild acidic environment of the cell suspension during the treatment. On the other hand, it has come to our attention that a recent PEF study by [@B17] did not result in as extensive changes in cells as what we have observed in our current study. Specifically, they reported that treating *E. coli* cells with 500 consecutive 60-ns pulses at 10^7^ V m^--1^, followed by a 1-h proteomic recovery in LB at room temperature, only led to the differential expression of one protein ([@B17]). We speculated that the discrepancies could have stemmed from the fact that they used considerably shorter pulses and detected proteins by two-dimensional gel electrophoresis, which, in theory, tends to afford a lower diversity of protein candidates.

The development of resistance in pathogenic microbes against PEF treatment poses a significant problem to food preservation. In some cases, such resistance seems to be temperature- and/or pH-dependent ([@B59]), suggesting the involvement of enzymes and/or other bioactive molecules that confer damage mitigation. Liu and coworkers pointed out that the composition of membrane fatty acids plays a key role in the PEF resistance of *E. coli* by regulating membrane fluidity ([@B34]). A similar conclusion has also been obtained by Cebrián ([@B3]). On the other hand, microbial cells can activate an oxidative stress response upon PEF treatment, which has been shown to produce excessive ROS ([@B49]). As evidence, [@B64] reported the up-regulation of several genes associated with oxidation stress, including those encoding glutathione synthase and superoxide dismutase, in PEF-stressed yeasts. Furthermore, the authors confirmed that the attenuation of such oxidative injuries strongly correlated with the PEF resistance of the cells ([@B64]). [@B12] suggested that enzymes involved in lipid biosynthesis and energy production are required for post-PEF membrane repair. In support of these findings, we demonstrated that PEF treatment significantly augmented the expression of several proteins involved in sulfate transport and reduction. This would in turn result in increased levels of sulfide and other reductive sulfur-containing species, presumably exerting a cytoprotective effect against PEF-induced oxidative stress ([@B58]; [@B48]; [@B73]). Taken together, these studies offered clear evidence that microorganisms can adopt a number of strategies to combat the detrimental effects of PEF.

In summary, we reported the first systematic proteomic profiling study on PEF-treated *E. coli*. The results that we obtained suggested that the application of PEF could significantly impact the membrane integrity of the cells and could potentially stimulate a wide range of cellular defense mechanisms. These results can help researchers better understand PEF-induced microbial inactivation and develop more effective PEF-based food processing methods.
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